Add to balance / Manage account | User: | Log out |
Prospect News home > News index > List of issuers B > Headlines for Boston Scientific Corp. > News item |
Moody’s rates Boston Scientific notes Baa3
Moody's Investors Service said it assigned a Baa3 to Boston Scientific Corp.’s new note offering.
The outlook is stable and existing ratings are unchanged.
Proceeds will be used to refinance upcoming maturities as well as partially fund its $1.6 billion planned acquisition of Endo's AMS men's health business.
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.